Molecular and structural discrimination of proline racemase and hydroxyproline-2-epimerase from nosocomial and bacterial pathogens

PLoS ONE

Volumn 2, Issue 9, 2007, Pages

  Goytia, Maira ^a   Chamond, Nathalie ^a   Cosson, Alain ^a   Coatnoan, Nicolas ^a   Hermant, Daniel ^a   Berneman, Armand ^a   Minoprio, Paola ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EPIMERASE; HYDROXYPROLINE 2 EPIMERASE; PROLINE RACEMASE; RACEMASE; UNCLASSIFIED DRUG; HYDROXYPROLINE EPIMERASE; ISOMERASE;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL METABOLISM; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BRUCELLA ABORTUS; BRUCELLA MELITENSIS; BRUCELLA SUIS; BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA PSEUDOMALLEI; CHAGAS DISEASE; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; DNA EXTRACTION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME STRUCTURE; MITOGENICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PSEUDOMONAS AERUGINOSA; TISSUE SPECIFICITY; TRYPANOSOMA CRUZI; VIBRIO PARAHAEMOLYTICUS; BACTERIAL INFECTION; CATALYSIS; CHEMISTRY; CROSS INFECTION; GENETICS; KINETICS; METABOLISM; MICROBIOLOGY; MOLECULAR GENETICS; MUTATION; SEQUENCE HOMOLOGY;

BACTERIA (MICROORGANISMS); BRUCELLA; BRUCELLA MELITENSIS BIOVAR ABORTUS; EUKARYOTA; TRYPANOSOMA CRUZI;

AMINO ACID ISOMERASES; AMINO ACID SEQUENCE; BACTERIAL INFECTIONS; CATALYSIS; CROSS INFECTION; KINETICS; MOLECULAR SEQUENCE DATA; MUTATION; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 41149138060     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0000885     Document Type: Article

References (34)

1. Stadtman TC, Elliott P (1957) Studies on the enzymic reduction of amino acids. II. Purification and properties of D-proline reductase and a proline racemase from Clostridium sticklandii. J Biol Chem 228(2): 983-997.
2. Belasco JG, Albery WJ, Knowles JR (1986) Energetics of proline racemase: double fractionation experiment, a test for concertedness and for transition-state dominance. Biochemistry 25(9): 2552-2558.
3. Fisher LM, Albery WJ, Knowles JR (1986) Energetics of proline racemase: racemization of unlabeled proline in the unsaturated, saturated, and over-saturated regimes. Biochemistry 25(9): 2529-2537.
4. Reina-San-Martin B, Cosson A, Minoprio P (2000) Lymphocyte polyclonal activittion: a pitfall for vaccine design against infectious agents. Parasitology today (Personal ed 16(2): 62-67.
5. Reina-San-Martin B, Degrave W, Rougeot C, Cosson A, Chamond N, et al. (2000) A B-cell mitogen from a pathogenic trypanosome is a eukaryotic proline racemase. Nat Med 6(8): 890-897.
6. Chamond N, Goytia M, Coatnoan N, Barale JC, Cosson A, et al. (2005) Trypanosoma cruzi proline racemases are involved in parasite differentiation and infectivity. Mol Microbiol 58(1): 46-60.
7. Chamond N, Coatnoan N, Minoprio P (2002) Immunotherapy of Trypanosoma cruzi infectious. Current drug targets 2(3): 247-254.
8. Chamond N, Gregoire C, Coatnoan N, Rougeot C, Freitas-Junior LH, et al. (2003) Biochemical characterization of proline racemases from the human protozoan parasite Trypanosoma cruzi and definition of putative protein signatures. J Biol Chem 278(18): 15484-15494.
9. Yoshimura T, Esak N (2003) Amino acid racemases: functions and mechanisms. Journal of bioscience and bioengineering 96(2): 103-109.
10. Buschiazzo A, Goytia M, Schaeffer F, Degrave W, Shepard W, et al. (2006) Crystal structure, catalytic mechanism, and mitogenic properties of Trypanosoma cruzi proline racemase. Proc Natl Acad Sci U S A 103(6): 1705-1710.
11. Adams E (1959) Hydroxyproline metabolism. I. Conversion to alpha-ketoglutarate by extracts of Pseudomonas. J Biol Chem 234(8): 2073-2084.
12. Radhakrishnan AN, Meister A (1957) Conversion of hydroxyproline to pyrrole-2-carboxylic acid. J Biol Chem 226(1): 559-571.
13. Spera JM, Ugalde JE, Mucci J, Comerci DJ, Ugalde RA (2006) A B lymphocyte mitogen is a Brucella abortus virulence factor required for persistent infection. Proc Natl Acad Sci U S A 103(44): 16514-16519.
14. Adams E (1970) Metabolism of proline and of hydroxyproline. Int Rev Connect Tissue Res 5: 1-91.
15. Prockop DJ, Kivirikko KI (1995) Collagens: molecular biology, diseases, and potentials for therapy. Annu Rev Biochem 64: 403-434.
16. Cardinale GJ, Abeles RH (1968) Purification and mechanism of action of proline racemase. Biochemistry 7(11): 3970-3978.
17. Adams E, Norton IL (1964) Purification and Properties of Inducible Hydroxyproline 2-Epimerase from Pseudomonas. J Biol Chem 239: 1525-1535.
18. Ramaswamy SG (1984) Hydroxyproline 2-epimerase of Pseudomonas. Subunit structure and active site studies. J Biol Chem 259(1): 249-254.
19. Bouza E, Munoz P, Alonso R (2005) Clinical manifestations, treatment and control of infections caused by Clostridium difficile. Clin Microbiol Infect 11 Suppl 4: 57-64.
20. Stoddart B, Wilcox MH (2002) Clostridium difficile. Curr Opin Infect Dis 15(5): 513-518.
21. Godfroid J, Cloeckaert A, Liautard JP, Kohler S, Fretin D, et al. (2005) From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis. Vet Res 36(3): 313-326.
22. Kipnis E, Sawa T, Wiener-Kronish J (2006) Targeting mechanisms of Pseudomonas aeruginosa pathogenesis. Med Mal Infect 36(2): 78-91.
23. Pappas G, Akritidis N, Bosilkovski M, Tsianos E (2005) Brucellosis. N Engl J Med 352(22): 2325-2336.
24. Sadikot RT, Blackwell TS, Christman JW, Prince AS (2005) Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am J Respir Crit Care Med 171(11): 1209-1223.
25. Wiersinga WJ, van der Poll T, White NJ, Day NP, Peacock SJ (2006) Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat Rev Microbiol 4(4): 272-282.
26. Macfarlane L, Oppenheim BA, Lorrigan P (1991) Septicaemia and septic arthritis due to Pseudomonas putida in a neutropenic patient. The Journal of infection 23(3): 346-347.
27. Harrington DJ (1996) Bacterial collagenases and collagen-degrading enzymes and their potential role in human disease. Infection and immunity 64(6): 1885-1891.
28. Miyoshi S, Shinoda S (2000) Microbial metalloproteases and pathogenesis. Microbes Infect 2(1): 91-98.
29. de Bentzmann S, Polette M, Zahm JM, Hinnrasky J, Kileztky C, et al. (2000) Pseudomonas aeruginosa virulence factors delay airway epithelial wound repair by altering the actin cytoskeleton and inducing overactivation of epithelial matrix metalloproteinase-2. Laboratory investigation; a journal of technical methods and pathology 80(2): 209-219.
30. Bejarano PA, Langeveld JP, Hudson BG, Noelken ME (1989) Degradation of basement membranes by Pseudomonas aeruginosa elastase. Infection and immunity 57(12): 3783-3787.
31. Gryder RM, Adams E (1969) Inducible degradation of hydroxyproline in Pseudomonas putida: pathway regulation and hydroxyproline uptake. J Bacteriol 97(1): 292-306.
32. Gryder RM, Adams E (1970) Properties of the inducible hydroxyproline transport system of Pseudomonas putida. J Bacteriol 101(3): 948-958.
33. Valle D, Blaese RM, Phang JM (1975) Increased sensitivity of lymphocyte delta1-pyrroline-5-carboxylate reductase to inhibition by proline with transformation. Nature 253(5488): 214-216.
34. Valle D, Downing SJ, Phang JM (1973) Proline inhibition of pyrroline-5-carboxylate reductase: differences in enzymes obtained from animal and tissue culture sources. Biochemical and biophysical research communications 54(4): 1418-1424.